| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |